Effects of complementary therapies associated with Cardiac Rehabilitation in patients with Chronic Heart Failure

Not Applicable

• Conditions: Cardiovascular diseases, Left Ventricular Failure; I50.1

• Registration Number: RBR-7zccgr
• Lead Sponsor: Departamento de Fisioterapia da Universidade Federal do Rio Grande do Norte

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-05
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

The patients present a diagnosis of stable chronic Heart failure who are undergoing medical follow-up with a cardiologist and present stable disease suggested by the absence of any change in medication and without previous diagnosis of moderate or severe chronic obstructive pulmonary disease, exercise-induced asthma and previous hospitalization history last 3 months and anginal events in the three months before the study, with left ventricular systolic dysfunction with LVEF <40% and New York Heart Association (NYHA) classification in classes II and III.

Exclusion Criteria

Patients with musculoskeletal diseases or any other situation that makes it impossible to perform aerobic or resisted exercises. To present worsening of signs and symptoms of HF after starting the proposed rehabilitation program. Present paradoxical breathing or persistent use of accessory breathing muscles or oxygen desaturation during the exercise program. Body mass index (BMI) <35 kg / m. Any individual with severe, significant arrhythmias or unable to perform the exercise protocol associated with Non- invasive ventilation (NIV) or Respiratory Muscle Training (RMT) will be excluded from the study

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Additional effects of complementary therapies to the cardiac rehabilitation program on the improvement of oxygen consumption, distance traveled during the six-minute walk test with telemetry, and analysis of gases and respiratory muscle strength with the manovacuometer from the observation of a variation of at least 5% in the pre- and post-intervention measurements

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected